Featuring Kennen MacKay, RBC Capital Markets’ Co-Head of Biotechnology Research
Before the pandemic, the challenges plaguing U.S. healthcare seemed insurmountable. Think onerous regulations, outdated processes, and high prices. But the dark clouds of the crisis are bringing silver linings – less red tape, virtual access to doctors, and long-awaited innovation. How are healthcare providers adapting? And what role will Big Tech play? Kennen MacKay, RBC Capital Markets’ Co-Head of Biotechnology Research, shares how changes in the U.S. healthcare sector are here to stay.
The 10-Minute Take podcast provides insights from RBC economists and market experts on events unfolding around the globe.
‡ For relevant conflicts disclosure, please visit our Disclosure Lookup Tool.
This article is intended as general information only and is not to be relied upon as constituting legal, financial or other professional advice. A professional advisor should be consulted regarding your specific situation. Information presented is believed to be factual and up-to-date but we do not guarantee its accuracy and it should not be regarded as a complete analysis of the subjects discussed. All expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change. No endorsement of any third parties or their advice, opinions, information, products or services is expressly given or implied by Royal Bank of Canada or any of its affiliates.